Immediate Impact

1 by Nobel laureates 2 from Science/Nature 69 standout
Sub-graph 1 of 22

Citing Papers

Rheumatoid arthritis: pathogenesis and therapeutic advances
2024 Standout
Multifunctional Janus Nanoplatform for Efficiently Synergistic Theranostics of Rheumatoid Arthritis
2023 Standout
5 intermediate papers

Works of Leon Gervitz being referenced

Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study
2016
Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol: A Post-hoc Analysis of the RAPID 1 Trial
2012
and 1 more

Author Peers

Author Last Decade Papers Cites
Leon Gervitz 61 57 199 95 66 15 348
Mariko Yamaoka 15 98 57 67 14 12 383
S. Sallmann 55 25 58 22 20 10 383
Inge E. van Es 57 28 71 30 5 12 405
Yiming Chen 22 15 47 11 39 29 332
Dyane Auclair 19 22 87 23 21 13 381
Kazuhiko Haruta 27 13 40 24 12 15 353
Cecily Q. Bernales 26 9 37 9 36 22 365
Claude Alain Maurage 32 178 42 14 6 17 408
G. Coppolino 31 8 102 13 7 17 395
Jagjit S. Gill 128 21 14 42 13 19 400

All Works

Loading papers...

Rankless by CCL
2026